EUVIMEDEUVIMED entdecken
Open Access

Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors

Yanhua Gao, Ira Bergman iD

Journal of Virology · 2023

DOI: 10.1128/jvi.00372-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Yanhua Gao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Glycoproteins, Oncolytic Virotherapy, Oncolytic Viruses. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new form of vesicular stomatitis virus (VSV) was created that specifically targets and destroys cancer cells that express the Her2/neu receptor. This receptor is commonly found in human breast cancer and is associated with a poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGlycoproteinsOncolytic VirotherapyOncolytic VirusesVesiculovirusAnimalsFemaleHumansMiceCell Line, TumorErb-b2 Receptor Tyrosine KinasesVirus ReplicationSurvival AnalysisPeptide Fragments

Stichwörter der Autor:innen

targeted vesicular stomatitis virusviral oncoimmunotherapyviral oncolysis

Substanzen

GlycoproteinsErb-b2 Receptor Tyrosine KinasesHER2-neu-derived peptide (780-786)Peptide Fragments

Autor:innen und Institutionen

  • Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Ira Bergman

Förderung

  • NIAID NIH HHS

Zitieren

APA

Gao, Y., & Bergman, I. (2023). Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors. Journal of Virology. https://doi.org/10.1128/jvi.00372-23

Vancouver

Gao Y, Bergman I. Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors. Journal of Virology. 2023. doi:10.1128/jvi.00372-23

BibTeX
@article{Gao2023,
  author = {Gao, Yanhua and Bergman, Ira},
  title = {Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors},
  journal = {Journal of Virology},
  year = {2023},
  doi = {10.1128/jvi.00372-23}
}
Kostenlos starten →